R0002/2026-03-13/C005/S02¶
WebSearch — RoB 2 COI Absence
Summary¶
| Field | Value |
|---|---|
| Source/Database | WebSearch |
| Results returned | 10 |
| Results selected | 2 |
| Results rejected | 0 |
Query¶
- Terms: "Cochrane RoB 2 conflict of interest funding bias domain absent missing"
- Filters applied: None
- Results returned: 10
Selected Results¶
| Result | Title | Rationale |
|---|---|---|
| S02-R01 | PMC10897924 — Sterne (argues against COI inclusion) | Co-developer's published defense of design choice |
| S02-R02 | PMC11147813 — Nejadghaderi et al. (discusses absence) | Peer-reviewed discussion of COI absence |
Rejected Results¶
[None — remaining results were secondary commentary.]
Notes¶
Targeted search for the COI/funding absence debate. Key discovery: a formal counterargument published by Sterne (a co-developer of RoB 2) explaining why funding should NOT be included. This finding is critical — it shows the absence is deliberate and defended, not merely an oversight.